RT Journal Article
SR Electronic
T1 Buruli ulcer Community Health Education and Medical Screening (BU-CHEMS) in Ga South District, Ghana
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.07.31.24311162
DO 10.1101/2024.07.31.24311162
A1 Narh, Charles A.
A1 Tetteh, Edwin
A1 ,
YR 2024
UL http://medrxiv.org/content/early/2024/08/02/2024.07.31.24311162.abstract
AB Background The National Service Personnel Association of the Noguchi Memorial Institute for Medical Research (NSPA-NMIMR) carries out an annual community outreach project comprising health education and medical screening for some of the diseases that the institute works on. Therefore, the NSPA 2009/2010 group (40 personnel) conducted Buruli ulcer community health education and medical screening (BU-CHEMS) in the Ga South District of Ghana in July 2010.Method BU is caused by mycobacterium ulcerans, and starts as a painless nodule, which can progress to ulcer, particularly on the upper and lower extremities. BU is often associated with witchcraft in some Ghanaian communities, and as a result, some patients reluctantly seek medical treatment. Therefore, prior to the screening program, the NSPA and medical staff from the Obom Health Centre showed video documentaries on BU as a way of educating and dispelling myths about the disease. This was followed by screening for nodules and ulcers among 2,500 people, mostly children in primary schools, residing in four endemic communities in the Ga South District. Other medical screening activities included blood group/pressure tests, Body Mass Index (BMI) and body temperature checks.Results and conclusion Suspected cases of BU (N=33) ranging from nodules, plagues, oedema and ulcers of the disease on various parts of the body including the lower and upper extremities were identified, and samples were sent to NMIMR for PCR confirmation. All the PCR-positive cases (78%), including children (<15 years, 88%) were referred to the Obom Health Center for clinical treatment. The BU-CHEMS organized by NSPA 2009/2010 group (with sponsorship from corporate organizations) contributed to NMIMR mandate: improving the health and wellbeing of Ghanaians and mankind through focused and relevant quality biomedical research, human resource development and support of national public health activities.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe project was supported by Noguchi Memorial Institute for Medical (NMIMR) University of Ghana) and the National Buruli Ulcer Control Programme (Korle-Bu Hospital) and the Obom Health Center and the Societe Generale Ghana (SG-SSB) bank, our main sponsor. The media stations TV3, GTV, Obonu fm, Citi fm, Radio Univers and Net 2 TV are duly acknowledged.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The project was supported by Noguchi Memorial Institute for Medical (NMIMR) University of Ghana), the National Buruli Ulcer Control Programme (NBUCP, Korle-Bu Hospital) and the Obom Health Center. These institutions provided written approval for the conduct of the project. The sample collection was embedded into a large BU diagnosis study, with ethics approval from the NMIMR Institutional Review Board. All participants consented prior to participating and having their samples taken for BU test confirmation at the Noguchi Memorial Institute for Medical Research, University of Ghana. Refreshment was provided for all participants.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript